BioSpace: Biotech, Pharmaceutical and Clinical Research News
WEB2024 Q2 Job Market Report: More People Competing for Fewer Job Openings. For the second quarter of 2024, there were 25% fewer jobs posted live on BioSpace compared to the same quarter of 2023. The year-over-year job response rate rose from 14.6% to …
News - BioSpace
WEBBioSpace is the digital hub for life science news and jobs. We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals who advance health and quality of life across the globe. The latest biotech and pharmaceutical news from BioSpace.
China - BioSpace
WEBHouse Speaker Plans to Vote, Pass BIOSECURE Act into Law This Year. House Speaker Mike Johnson (R-La.) on Monday said he intends to have a “significant package of China-related legislation” signed into law by the end of this year, including the BIOSECURE Act which intends to stop federal contracts with Chinese “companies of concern ...
U.S. grants Vidac Pharma patent offering broad protection of
WEB1 day ago · London (UK), September 19 2024 – Vidac Pharma Holdings Plc.(Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company pioneering a novel class of cancer treatments, today announces that the United States Patent and Trademark Office (USPTO) has issued a …
Positive phase III results show Xofluza significantly reduces the ...
WEB1 day ago · Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from an infected person to household members; This is the first time that any antiviral used in the treatment of a respiratory viral illness has demonstrated a transmission reduction benefit in a global phase III study
Willow Announces a Second Program With Global Ingredient
WEB1 day ago · Rapid success of first program leads to second collaboration to develop optimized enzyme for large scale manufacturing process. Enzyme development expected to enable commercial-scale production of the API in 2025
Clinical research - BioSpace
WEBAug 12, 2024 · Pelage Pharmaceuticals Advances Clinical Program with First Patients Dosed in Phase 2 Study for Hair Loss and GV-Led $14M Series A-1. August 13, 2024. 4 min read. Sionna Therapeutics Announces Initiation of Two Phase 1 Clinical Trials of SION-719 and SION-451, in Development for Cystic Fibrosis.
Phase III Clinical Trials - BioSpace
WEBSep 11, 2024 · AstraZeneca’s Imfinzi Fails Phase III NSCLC Trial, Aces Late-Stage Bladder Cancer Study. AstraZeneca’s PD-L1 inhibitor failed to significantly improve disease-free survival in patients with non-small cell lung cancer, but hit its primary endpoint in a late-stage trial in muscle-invasive bladder cancer. June 25, 2024.
Medical device - BioSpace
WEBApr 1, 2024 · J&J’s ‘Pretzel’ Drug-Device Combo Scores in Mid-Stage Bladder Cancer Study. Following the regulatory victory of Balversa in urothelial carcinoma, Johnson & Johnson on Friday continued its bladder cancer winning streak with an 82.8% complete response rate forTAR-200 in high-risk non-muscle invasive bladder cancer. May 6, 2024.
Cancer - BioSpace
WEBFDA Adcomm Calls for Changes in Perioperative Lung Cancer Trials. The FDA’s Oncologic Drugs Advisory Committee on Thursday strongly supported changing clinical trials for non-small cell lung cancer drugs given in the perioperative setting, pointing out the need for a more nuanced approached to treatments before and after surgery. July 26, 2024.